SOURCE: Eurand N.V.

Eurand N.V.

March 10, 2010 08:45 ET

Eurand to Present at Barclays Capital Global Healthcare Conference

PHILADELPHIA, PA--(Marketwire - March 10, 2010) -  Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is scheduled to present at the upcoming Barclays Capital 2010 Global Healthcare Conference. Gearóid Faherty, Eurand's Chairman and Chief Executive Officer, will be presenting.

  Date: Wednesday, March 24, 2010
  Time: 10:15 a.m. ET
  Location: Loews Hotel, Miami, Fla.

An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's website at A replay of the presentation will be available for 30 days.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking/ orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit

Contact Information

  • Contacts:
    Bill Newbould
    Vice President, Investor Relations
    Eurand N.V.
    +1 267-759-9335
    Email Contact

    Nick Laudico/Sara Pellegrino
    The Ruth Group
    +1 646-536-7030/7002
    Email Contact
    Email Contact